Entera Bio LTD. (ENTX) — DEF 14A Filings
All DEF 14A filings from Entera Bio LTD.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Entera Bio Shares Soar 212% in 2 Years Amidst Executive Pay Disclosures
— Jun 5, 2025 Risk: medium
Entera Bio Ltd.'s DEF 14A filing, dated June 5, 2025, primarily details executive compensation and its relationship to company performance, specifically focusin -
Entera Bio Ltd. Executive Compensation Details Revealed
— Jun 20, 2024 Risk: low
Entera Bio Ltd. filed a DEF 14A detailing executive compensation for 2023 and 2022. Miranda Toledano served as Executive Officer, with Hillel Galitzer and Dana
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX